Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines

dc.contributor.authorTyne, Anneliese S.
dc.contributor.authorChan, John Gar Yan
dc.contributor.authorShanahan, Erin R.
dc.contributor.authorAtmosukarto, Ines
dc.contributor.authorChan, Hak-Kim
dc.contributor.authorBritton, Warwick
dc.contributor.authorWest, Nicholas P.
dc.date.accessioned2015-12-10T23:19:53Z
dc.date.issued2013
dc.date.updated2016-02-24T12:04:17Z
dc.description.abstractDespite considerable research efforts towards effective treatments, tuberculosis (TB) remains a staggering burden on global health. Suitably formulated sub-unit vaccines offer potential as safe and effective generators of protective immunity. The Mycobact
dc.identifier.issn0264-410X
dc.identifier.urihttp://hdl.handle.net/1885/66093
dc.publisherElsevier
dc.sourceVaccine
dc.subjectKeywords: bacterial protein; immunoglobulin G; lipokel; Mycobacterium vaccine; unclassified drug; antibody response; antigen presenting cell; article; controlled study; dendritic cell; dry powder; female; immunization; lung tuberculosis; mediastinum lymph node; mou Cutinase-like protein1-6; Lipokel; MPT83; Powdered pulmonary vaccine; TLR-2; Tuberculosis
dc.titleTLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines
dc.typeJournal article
local.bibliographicCitation.issue40
local.bibliographicCitation.lastpage4329
local.bibliographicCitation.startpage4322
local.contributor.affiliationTyne, Anneliese S., Centenary Institute
local.contributor.affiliationChan, John Gar Yan, University of Sydney
local.contributor.affiliationShanahan, Erin R., Centenary Institute
local.contributor.affiliationAtmosukarto, Ines, Non-ANU institution, Lipotek
local.contributor.affiliationChan, Hak-Kim, University of Sydney
local.contributor.affiliationBritton, Warwick, University of Sydney
local.contributor.affiliationWest, Nicholas P., Centenary Institute
local.contributor.authoruidAtmosukarto, Ines, u3881315
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110309 - Infectious Diseases
local.identifier.ariespublicationu9511635xPUB1215
local.identifier.citationvolume31
local.identifier.doi10.1016/j.vaccine.2013.07.022
local.identifier.scopusID2-s2.0-84882896414
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Tyne_TLR2-targeted_secreted_2013.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format